Fundz

Intensity Therapeutics reported raising $3.65 Million in an initial SEC Form D filing, from an offering of $3.65 Million

PUBLIC · INTSDec 05, 2024

Amount Raised

$3.65 Million

$3.65 Million sold, per SEC Form D (first sale Nov 21, 2024)

Round Type

Seed

SheltonManufacturingBiotechnologyHealth CareTherapeutics

Quick answer

Intensity Therapeutics raised $3.65 Million in a Seed round, dated November 21, 2024. Intensity Therapeutics is based in Shelton, Connecticut, United States.

How much did Intensity Therapeutics raise?
Intensity Therapeutics raised $3.65 Million in a Seed round on November 21, 2024.
What does Intensity Therapeutics do?
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers.
Where is Intensity Therapeutics based and how big is it?
Intensity Therapeutics is based in Shelton, Connecticut, United States.
Who are the decision-makers at Intensity Therapeutics?
Fundz holds 1 contact at Intensity Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Intensity Therapeutics, and when

A new round usually means Intensity Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Intensity Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Intensity Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Intensity Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Intensity Therapeutics

Location

Shelton, Connecticut, United States

About

Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Intensity Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Intensity Therapeutics's next move

See what Strategic adds

Intensity Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.